EUVIMEDTutustu EUVIMEDiin
ÜbersichtsarbeitOpen access

Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities

Chengyuan Li, Jianing Zhou, Lijun Zhang, Yan Si, Xiang Zhang, Meiping Shen

Journal of Cancer · 2026-01-01 · 17 (2) · 290-299

DOI: 10.7150/jca.122078 ↗

At a glance

Übersichtsarbeit in Journal of Cancer, published on 2026-01-01. Written by Chengyuan Li and 5 co-authors. Institution: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, China. Cited 3 times so far (Crossref). The full text is freely available in PubMed Central.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Thyroid carcinoma (TC) is the most prevalent malignancy of the endocrine system, with its incidence rising annually worldwide. Post-translational modifications and epigenetic changes have been documented to be pivotal in the initiation, progression, and malignant transformation of TC. In addition to mediating biological processes such as cell recognition, signal transduction, and immune regulation, these modifications can also significantly impact the development and metastasis of various cancers. Among these, sialylation is identified as a key post-translational modification, showing close associations with the invasiveness and metastatic potential of TC. This review aims to provide an overview of the current understanding of sialylation in TC, highlighting its underlying mechanisms and examining its roles in cell proliferation, invasion, and immune evasion. Additionally, this study intends to explore the potential of targeting sialylation as a novel therapeutic approach, providing new perspectives for TC prevention and treatment, as well as the development of new therapeutic agents.

Subjects

Author keywords

sialic acid-binding immunoglobulin-like lectinssialylationthyroid carcinoma

Authors and institutions

  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, China.

Cite

APA

Li, C., Zhou, J., Zhang, L., Si, Y., Zhang, X., & Shen, M. (2026). Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. Journal of Cancer, 17(2), 290-299. https://doi.org/10.7150/jca.122078

Vancouver

Li C, Zhou J, Zhang L, Si Y, Zhang X, Shen M. Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. Journal of Cancer. 2026;17(2):290-299. doi:10.7150/jca.122078

BibTeX
@article{Li2026,
  author = {Li, Chengyuan and Zhou, Jianing and Zhang, Lijun and Si, Yan and Zhang, Xiang and Shen, Meiping},
  title = {Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities},
  journal = {Journal of Cancer},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {290--299},
  doi = {10.7150/jca.122078}
}
Start for free →